Background: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), the dysfunctional Cl -channel in Cystic Fibrosis, undergoes complex biosynthesis at the endoplasmic reticulum involving several molecular chaperones including Hsp70 and many co-chaperones. Bcl-2-associated athanogenes (BAGs) constitute a protein family sharing an Hsc70-binding domain. BAG-1 possesses an ubiquitin-like domain (Ub-LD) responsible for proteasomal association and for promoting substrate release from Hsc70/Hsp70 in vitro by accelerating the chaperone ATP/ADP exchange rate. Methods: Herein, we studied the in vivo effect of BAG-1 on the turnover and processing of wild type (wt)-and F508del-CFTR, the most frequent mutation in CF patients. Results: Results show that BAG-1 associates with both wt-and F508del-CFTR (in higher yields with the latter) through its Ub-LD and independently of Hsc70. Moreover, the immature form of F508del-CFTR (but not of wt-CFTR) is stabilized by BAG-1 overexpression, albeit in a cell-type specific way, without detectable maturation. Data also show that BAG-1 and the proteasome inhibitor ALLN are not additive on stabilizing F508del-CFTR and this effect depends on BAG-1 Ub-LD. Moreover, under BAG-1 overexpression, a reduction in ubiquitinylated-CFTR occurs suggesting that BAG-1 competes with Ub. Conclusion: Overall, data are compatible with a mechanism in which BAG-1 stabilizes F508del-CFTR by direct binding, probably competing out ubiquitin to partially avoid its proteasomal degradation.
BAG-1 Stabilizes Mutant F508del-CFTR in a Ubiquitin-Like-Domain-Dependent Manner

Introduction
The genetic disease Cystic Fibrosis is caused by mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) which lead to the absence or malfunction of CFTR protein, a cAMP-regulated Cl -channel localized at the apical membrane of epithelial cells. The most prevalent disease-causing mutation, found in about 90% of CF patients, is the deletion of a phenylalanine residue at position 508 (F508del) [1] .
CFTR is a member of the ABC (ATP-binding cassette) transporters super-family, and its structure comprises two membrane-spanning domains (MSDs), two nucleotide-binding domains (NBDs) and a regulatory domain (RD). Given its multi-domain structure, CFTR undergoes a fairly complex biosynthetic pathway at the endoplasmic reticulum (ER) [2] in which several molecular chaperones and co-chaperones from both the ER-membrane and the cytosol have been shown to participate. These include: Hsp70/Hsc70 [3] , calnexin [4, 5] , Hdj-2 [6] , Hsp90 [7] , Hdj-1/Hdj-2 [5, 8] , HspBP1 [9] , (reviewed in [2] ), CHIP, BAG-2 [10] and cysteine string protein (Csp) shown to regulate the exit of CFTR from the ER and Hsc70/ Hsp70-CHIP-mediated CFTR degradation [11] .
CFTR biogenesis initiates with its co-translational folding into the ER membrane where the protein is core-glycosylated, originating an immature precursor form (~145 KDa), known as band B. Wild-type (wt)-CFTR undergoes maturation through the Golgi, originating a ~170-kDa complex form (band C) [12] . Depending on the cell type, only a fraction (25% to 70%) of precursor wt-CFTR matures [13] , the remaining undergoes ubiquitination (Ub) and degradation by the proteasomal pathway (UPP) [14, 15] . Far less F508del-CFTR (undetectable in most cell types) leaves the ER due to its inefficient folding and incomplete conformational maturation [13] . Indeed, the ER quality control (ERQC) targets the misfolded protein to UPPdegradation [14, 15] and thus very little protein reaches the cellular membrane. However, proteasome inhibitors only partially prevent CFTR degradation, indicating that key factors in the CFTR degradative pathway remain unidentified [14, 15] .
We have previously shown that co-overexpressing Hsp70 and Hsp40 [5] stabilizes wtbut not F508del-CFTR. Our studies with glycosidase inhibitors and the ER-chaperone calnexin have also shown that calnexin-mediated and glycan-dependent ER-associated degradation (GERAD) occurs for wt-CFTR, but that most F508del-CFTR undergoes glycan-independent ER-associated degradation (ERAD) through an earlier, plausibly Hsc70/Hsp70-mediated proteolytic pathway [16] . These results, together with data from several other groups, led us to propose a multi-checkpoint model for the ERQC where wt-and F508del-CFTR are mostly discarded at two different major ERQC checkpoints, having as major mediators the calnexin and Hsc70-machineries, respectively [16] . More recently, we have proposed the existence of a third checkpoint mediated by recognition of arginine-framed tripeptides, or AFTs [17] . Notwithstanding, the ERQC checkpoint mediated by Hsc70 remains the most critical for retention and degradation of F508del-CFTR [16] .
A number of Hsc70 interactors (e.g., co-chaperones) are known to regulate Hsc70 activity towards a pro-folding or pro-degradative pathway for Hsc70 client proteins (reviewed in [2] ). Among these are the Bcl-2-associated athanogenes (BAGs)-family proteins, which were originally identified by their ability to associate with the anti-apoptotic protein Bcl-2 [18] . Thus far, BAG proteins have been reported to affect diverse cellular behaviours ranging from cell division and apoptosis to cell migration and differentiation by modulating the activity of molecular chaperones, protein kinases, receptor signalling and transcription factors [19] . BAG-1, the founding member of the BAG family [18, 20] is also a co-chaperone of Hsc70 [21, 22] and in vitro it was shown to promote substrate release from Hsc70 and ATP hydrolysis by accelerating the ATP/ADP exchange rate [21, 22] . BAG-family proteins share a conserved domain of approximately 100 amino acids in length responsible for Hsc70 binding, also called the BAG domain (BD), which modulates (positively or negatively) the activity of this chaperone, but differ in their N-terminus depending on the translation initiation site. [19] . BAG-1 also possesses an Ub-like domain (Ub-LD) at its amino-terminus which was proposed to constitute a physical link between the Hsp70/Hsc70 machinery and the proteasome S]-methionine (ICN Biomedicals, Irvine, CA, USA). Pulse-chase experiments, followed by IP with an anti-CFTR Ab were performed as previously described [5] . Where indicated, cells were incubated before the pulse with 200 µM ALLN (Sigma) for 120 min [32] . Briefly, cells were chased for the indicated time periods in complete medium supplemented with 1 mM nonradioactive methionine, lysed in 1 ml of RIPA buffer and CFTR IP carried out with an anti-CFTR Ab and Protein G-Agarose beads (Roche, Basel, Switzerland). Immunoprecipitated proteins were eluted with sample buffer and then separated by SDS-PAGE. SDS-PAGE, fluorography, densitometry and statistical analysis were also as described [5] . Differences are considered as significant for p values < 0.05.
Pull-down assays
For the pull-down assays, cells were lysed in chaperone buffer [50 mM Tris, 150 mM NaCl, 10 mM ammonium molybdate, 0.09% (v/v) NP40, pH 7.4] and CFTR was immunoprecipitated with an anti-CFTR Ab and Protein G-Agarose beads as above (Roche). Immunoprecipitated proteins were eluted with sample buffer for 1h at room temperature, electrophoretically separated by SDS-PAGE and immunoblotted as described above.
Results
BAG-1 expression after transient transfection and under stress conditions
Since BAG-1 acts as a modulator of the activity of Hsc70/Hsp70 chaperone, we tested whether its overexpression affects biosynthesis or maturation of wt-CFTR and F508del-CFTR. First, we transfected cells stably expressing the normal or mutant (F508del) forms of CFTR with a recombinant expression vector containing BAG-1 cDNA, or with the empty vector (mock) as a negative control and we evaluated the expression of the heterologous BAG-1 (mouse) by Western blot (Fig. 1A) . Results obtained show that the AF815 antibody (Ab) did not detected BAG-1 in mock-transfected cells (lanes 1,3) but only in significant levels 24h post-transfection with the BAG-1 construct, either in wt-or F508del-CFTR CHO expressing cells (lanes 2,4, respectively). The BAG-1 Ab used here is able to detect the 3 different BAG-1 mouse isoforms, as described by the manufacturer (see Methods). Densitometric analysis of the results evidences the increase in the amount of immature F508del-CFTR at steady state under BAG-1 overexpression (Fig. 1A , lane 4, upper panel and Fig. 1B ).
To look for a possible effect of BAG-1 in regulating Hsp70 expression (or vice-versa), which in turn might influence CFTR biogenesis [5, 33] , we then assessed Hsp70 levels under heat-shock (HS) stress (Fig. 1C ) in CHO cells with and without BAG-1 overexpression. By using the SPA-812 anti-Hsp70 Ab, which does not recognize the constitutive variant Hsc70 (see Methods), Hsp70 was only immunodetected when wt-or F508del-CFTR cells were subjected to HS (lanes 2, 4, 6 and 8). These results confirm a HS triggered Hsp70 induction as expected. However, neither BAG-1 nor the liposome transfection per se induced a stress response, as shown by lack of Hsp70 induction in either mock-(lanes 1, 5) or BAG-1-transfected non-HS cells (lanes 3, 7), in contrast to viral methods of DNA delivery [34] . Interestingly, the induction of Hsp70 which is very intense at recovery post-HS (18h) in mock-transfected cells (lanes 2 and 6 in Fig. 1C ) as expected, is drastically reduced in wtor F508del-CFTR cells overexpressing BAG-1 (Fig. 1C, lanes 4 and 8) . Conversely, BAG-1-transfection consistently resulted in lower BAG-1 expression levels in cells subjected to HS (Fig. 1D , lanes 6, 7 and 8, respectively), in comparison to non-HS cells (Fig. 1D, lane 5) .
In vivo effect of BAG-1 on the processing and degradation of wt-CFTR
To assess the effect of BAG-1 overexpression on the turnover rate and processing efficiency of wt-CFTR, metabolic pulse-chase experiments followed by CFTR IP were performed in CHO cells stably expressing wt-CFTR ( Fig. 2A) .
Data show no apparent effect of BAG-1 overexpression either in the turnover rate of immature wt-CFTR (band B) or in its processing efficiency into the mature form, band C ( Fig. 2A, lanes 7-12) in comparison to mock-transfected cells ( Fig. 2A, lanes 1-6) . Results plotted graphically after densitometric analysis of immature and mature forms validate these observations (Fig. 2B and C, respectively) . Indeed, statistical comparison of the slopes of the two lines (see Methods) confirmed that the degradation rate of the core-glycosylated form of wt-CFTR (band B) after BAG-1 transfection was not significantly altered relative to mock-transfected cells (Fig. 2B) . Similarly, no significant difference occurred between the 5) . As a loading control, filters were probed for β-actin.
maturation efficiency of wt-CFTR in mock-and BAG-1-transfected cells (Fig. 2C) being of approximately 40%, in agreement with previous studies in these cells [5, 16, 17] .
In vivo effect of BAG-1 on the processing and degradation of F508del-CFTR
Similarly to wt-CFTR experiments, we also assessed the effect of BAG-1 overexpression on the turnover and processing of F508del-CFTR stably expressed in CHO cells (Fig. 3A) . Data show that the turnover rate of immature F508del-CFTR in cells transfected with in BAG-1 is decreased in comparison to that in cells transfected with the empty vector (Fig.  3B ). Although small, this effect was reproducible and statistically significant (p<0.05). Nevertheless, we could not detect maturation of F508del-CFTR into the fully-glycosylated form under BAG-1 overexpression (Fig. 3A, lanes 7-12) .
To further characterize the stabilization of F508del-CFTR by BAG-1, we determined whether inhibition of the proteasome further enhanced CFTR stability under BAG-1 overexpression. Summary of data from pulse-chase analysis (Fig. 3C) shows that the proteasome inhibitor ALLN causes a stabilization of immature F508del-CFTR in mocktransfected cells when compared to cells incubated only with DMSO (compare 1 st and 2 nd bars in Fig. 3C ). As shown above, transfection with BAG-1 causes a stabilization of immature 
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F508del-CFTR (compare 1 st and 3 rd lanes in Fig. 3C ). However, ALLN causes no further stabilization of immature F508del-CFTR in BAG-1-transfected cells in comparison to vehicletreated cells (Fig. 3C, last two bars) , suggesting that the presence of BAG-1 may prevent F508del-CFTR from the UPP.
To further characterize this effect, we also assessed if this stabilization was observed if cells were transfected with BAG-1-∆N, a BAG-1 variant lacking the N-terminus, corresponding to its ubiquitin-like domain (Ub-LD). F508del-CFTR Band B stability was assessed by pulsechase in cells transfected with either this variant or mock-transfected (Fig. 3D) . Quantification of Band B remaining at 1h of chase shows that, contrary to full-length BAG-1, this deletion variant does not promote stabilization of mutant CFTR (Fig. 3E) , which presents turnover levels similar to those in the untransfected control.
Down-regulation of BAG-1 destabilizes F508del-CFTR expressed in human bronchial cells
In order to assess whether BAG-1 down-regulation caused the opposite effect on CFTR, we had to use a different cell line because neither CHO nor BHK cells express BAG-1 endogenously. Accordingly, we used the human bronchial epithelial cell lines CFBE, transduced to stably express either wt-or F508del-CFTR. These cell lines have endogenous BAG-1 expression, thus allowing its down-regulation through siRNA transfection. 
CFBE-wt or F508del cells were transfected with either a siRNA specific for BAG-1 or a scrambled siRNA (negative control). Protein extracts were collected 48h, 72h or 96h posttransfection and analysed by WB for either BAG-1 or CFTR (Fig. 4A ). We were able to detect down-regulation of BAG-1 levels to about 70% of control-transfected cells (Fig. 4A-C) . At this reduction of BAG-1 levels, we detected a decrease in the steady-state levels of F508del-CFTR that is, however, not observed for wt-CFTR (Fig. 4B , compare grey and black bars).
Characterization of a possible association in vivo between of BAG-1 and CFTR
Since BAG-1 has been shown to interact directly with multiple cellular targets, it seems plausible that BAG-1 may also associate in vivo with CFTR. However, since BAG-1 can also bind to Hsc70/Hsp70 [21, 22] and Hsc70/Hsp70 also associates with CFTR, an indirect interaction between CFTR and BAG-1 can also occur using Hsc70/Hsp70 as mediator.
To distinguish between these two possibilities, we used additional BAG-1 constructs, which also clarify which of the two BAG-1 functional domains (C-term-Hsp70-binding or N-term-Ub-LD) are required for the in vivo CFTR/BAG-1 interaction. Constructs used were (Fig. 5A ): BAG-1-∆N lacking the Ub-like domain (Ub-LD); BAG-1-∆C that misses the critical residues for Hsc70/Hsp70 interaction, also called the BAG domain (BD); and BAG-1 90-200, missing the first 90 aa (Ub-LD) and the last 19 aa (part of the BD), used here as a null control.
Results from pull-down of CFTR followed by immunoblotting of BAG-1 (Fig. 5B) show that full-length BAG-1 associates with both wt-CFTR (lane 2) and F508del-CFTR (lane 7), but in higher yields with the latter. The same result was obtained for BAG-1-∆C, lacking the aa residues required for interaction with Hsc70/Hsp70, with both wt-CFTR and F508del-CFTR 
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Together with the stabilization effect that it causes on F508del-CFTR (Fig. 3) , these results suggest that, through direct binding via its Ub-LD, BAG-1 may compete with Ub towards F508del-CFTR binding, partially preventing proteasomal degradation of the latter. To further investigate this mechanistic role of BAG-1 as a competitor of ubiquitin for F508del-CFTR binding, we examined the appearance of ubiquitinated forms of CFTR under BAG-1-overexpression. To this end, CHO cells stably expressing wt-or F508del-CFTR and transfected with either BAG-1 or the empty vectors were incubated with the proteasome inhbitor ALLN or DMSO (vehicle). After CFTR IP, its ubiquitinated forms were detected by WB with an anti-polyUb Ab (Fig. 5C) . Results show that treatment of wt-CFTR expressing cells with ALLN causes the appearance of ubiquitinated (high molecular mass) forms of CFTR in either mock-or BAG-1-transfected cells in equivalent amounts (Fig. 5C, lanes 2 and  4, respectively) . Similarly, when mock-transfected F508del-CFTR cells are treated with ALLN, a significant accumulation of Ub-CFTR is observed in comparison to vehicle-treated cells (Fig. 5C, lanes 8 and 7, respectively) . In contrast, in BAG-1-transfected cells, ALLN treatment does not cause Ub-CFTR to accumulate, as shown by the similar (and low) levels of Ub-CFTR forms in F508del-CFTR cells treated with either ALLN or vehicle (Fig. 5C , lanes 6 and 5, respectively). These data further indicate that BAG-1 overexpression precludes F508del-CFTR from undergoing polyubiquitination.
Moreover, when the same experiment was performed using BAG-1-∆N (lacking the Ub-LD) instead of full-length BAG-1, to transfect F508del-CFTR expressing cells, the ALLNtreatment caused again appearance of high molecular Ub-F508del-CFTR forms, which were in equivalent amounts to those in mock-transfected cells (Fig. 5D, lanes 4 and 2, respectively). This result shows that the Ub-LD of BAG-1, above demonstrated to be required for the association of BAG-1 with CFTR, is required to prevent occurrence of F508del-CFTR ubiquitination under ALLN.
Discussion
The main purpose of this study was to contribute to the basic understanding of the mechanism of ER retention and ER-associated degradation (ERAD) of the most common mutant protein responsible for Cystic Fibrosis -F508del-CFTR. The identification of components of the machinery retaining the mutant protein in the ER and selecting it for the proteolytic pathway may lead to a better understanding of this process. Ultimately, this may help to develop agents that promote cell surface rescuing of F508del-CFTR, in a therapeutic strategy aimed at correcting the basic defect in CF.
Overexpression of BAG-1 confers protection from the stress response
Induction of cytosolic molecular chaperones, e.g., Hsp70 and Hsp90, is a major protective mechanism against cellular stress and constitutes the so-called HS response. The activation of this pathway occurs mostly through transcriptional regulation of heat shock factor 1 (HSF1), which binds to HS elements located in the promoter region of HS genes leading to an increase in their expression. The response to HS is also subjected to negative feedback regulation through which overproduction of Hsp70 attenuates HSF1 activity by direct binding to the monomeric factor, inactivating it (reviewed in [35] ).
Here, we show that the well-known induction of Hsp70, which follows a HS treatment as widely described [36, 37] , is drastically reduced in cells overexpressing BAG-1. We interpret these data by the described effect of BAG-1 in promoting substrate release from Hsp70 [21, 22] , which thus makes more Hsp70 available for the feedback inhibition of HSF1 [35] . This constitutes novel in vivo evidence of an inhibitory effect of BAG-1 on Hsp70 induction by HS. Indeed, BAG-1 has been described to induce conformational changes in Hsp70 upon binding to its ATPase domain [38] , this interaction plausibly reduces Hsp70 binding affinity to ATP, hence inhibiting the Hsp70 chaperone activity [39] . This is consistent with the previously reported role of BAG-1 inhibiting Hsp70 activity in vivo, even overriding the stimulatory
